These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 39285048)
1. The passing of the creator of dolly and other pioneers, endocrine disruptors, metabolic syndrome, and more. Stratakis CA Hormones (Athens); 2024 Sep; 23(3):359-360. PubMed ID: 39285048 [No Abstract] [Full Text] [Related]
2. Twenty-Five Years of Endocrine Disruption Science: Remembering Theo Colborn. Kwiatkowski CF; Bolden AL; Liroff RA; Rochester JR; Vandenbergh JG Environ Health Perspect; 2016 Sep; 124(9):A151-4. PubMed ID: 27580976 [TBL] [Abstract][Full Text] [Related]
3. Neuroendocrine disruption: historical roots, current progress, questions for the future. Gore AC; Patisaul HB Front Neuroendocrinol; 2010 Oct; 31(4):395-9. PubMed ID: 20638407 [No Abstract] [Full Text] [Related]
4. Combinatorial pathway disruption is a powerful approach to delineate metabolic impacts of endocrine disruptors. Bernal K; Touma C; Erradhouani C; Boronat-Belda T; Gaillard L; Al Kassir S; Le Mentec H; Martin-Chouly C; Podechard N; Lagadic-Gossmann D; Langouet S; Brion F; Knoll-Gellida A; Babin PJ; Sovadinova I; Babica P; Andreau K; Barouki R; Vondracek J; Alonso-Magdalena P; Blanc E; Kim MJ; Coumoul X FEBS Lett; 2022 Dec; 596(24):3107-3123. PubMed ID: 35957500 [TBL] [Abstract][Full Text] [Related]
5. The toxic origins of disease. Gross L PLoS Biol; 2007 Jul; 5(7):e193. PubMed ID: 17594178 [TBL] [Abstract][Full Text] [Related]
6. Andrea Gore: neuroendocrinologist and environmental activist. Mitchell F Lancet Diabetes Endocrinol; 2020 Aug; 8(8):671. PubMed ID: 32707114 [No Abstract] [Full Text] [Related]
7. Life style-related diseases of the digestive system: endocrine disruptors stimulate lipid accumulation in target cells related to metabolic syndrome. Wada K; Sakamoto H; Nishikawa K; Sakuma S; Nakajima A; Fujimoto Y; Kamisaki Y J Pharmacol Sci; 2007 Oct; 105(2):133-7. PubMed ID: 17928741 [TBL] [Abstract][Full Text] [Related]
8. Endocrine disruptors and polycystic ovary syndrome: a focus on Bisphenol A and its potential pathophysiological aspects. Palioura E; Kandaraki E; Diamanti-Kandarakis E Horm Mol Biol Clin Investig; 2014 Mar; 17(3):137-44. PubMed ID: 25372737 [TBL] [Abstract][Full Text] [Related]
9. Editorial: Centennial Celebration - A Focus on Endocrine Disrupting Chemicals… One Hundred Years in the Making. Kraus WL Mol Endocrinol; 2016 Aug; 30(8):827-8. PubMed ID: 27477638 [No Abstract] [Full Text] [Related]
10. Endocrine Disruptors and the Induction of Insulin Resistance. Vanni R; Bussuan RM; Rombaldi RL; Arbex AK Curr Diabetes Rev; 2021; 17(7):e102220187107. PubMed ID: 33092513 [TBL] [Abstract][Full Text] [Related]
11. Editorial: Centennial Celebration - An Interview With Dr Ana Soto on 25 Years of Research on Endocrine-Disrupting Chemicals. Mol Endocrinol; 2016 Aug; 30(8):829-32. PubMed ID: 27477639 [No Abstract] [Full Text] [Related]
12. Metabolic syndrome: older than usually assumed, but still too young to die. Meisinger C; Koletzko B; Heinrich J Clin Chem; 2006 May; 52(5):897-8; author reply 898-9. PubMed ID: 16638959 [No Abstract] [Full Text] [Related]
13. Steroids and endocrine disruptors--History, recent state of art and open questions. Hampl R; Kubátová J; Stárka L J Steroid Biochem Mol Biol; 2016 Jan; 155(Pt B):217-23. PubMed ID: 24816231 [TBL] [Abstract][Full Text] [Related]
14. Bisphenol A and its analogs: Do their metabolites have endocrine activity? Gramec Skledar D; Peterlin Mašič L Environ Toxicol Pharmacol; 2016 Oct; 47():182-199. PubMed ID: 27771500 [TBL] [Abstract][Full Text] [Related]
15. The metabolic syndrome: there's little that's new under the sun! Frohlich ED J Cardiometab Syndr; 2006; 1(5):293-4. PubMed ID: 17679798 [No Abstract] [Full Text] [Related]
16. [The concept of metabolic syndrome. Its history and disease concept]. Yamada N Nihon Naika Gakkai Zasshi; 2004 Apr; 93(4):635-41. PubMed ID: 15174706 [No Abstract] [Full Text] [Related]
17. Reform of the Toxic Substances Control Act (TSCA): An Endocrine Society Policy Perspective. Vandenberg LN Endocrinology; 2016 Dec; 157(12):4514-4515. PubMed ID: 27911149 [No Abstract] [Full Text] [Related]
18. [Potential sources of phthalates and bisphenol A and their significance in the development of metabolic diseases]. Mráz M; Svačina Š; Kotrlíková E; Piecha R; Vrbík K; Pavloušková J; Lacinová Z; Vavrouš A; Müllerová D; Matějková D; Křížová J Cas Lek Cesk; 2016; 155(3):11-5. PubMed ID: 27256142 [TBL] [Abstract][Full Text] [Related]
19. The long-term effects of in utero exposures--the DES story. Goodman A; Schorge J; Greene MF N Engl J Med; 2011 Jun; 364(22):2083-4. PubMed ID: 21506735 [No Abstract] [Full Text] [Related]
20. An amphibian high fat diet model confirms that endocrine disruptors can induce a metabolic syndrome in wild green frogs (Pelophylax spp. complex). Veyrenc S; Regnault C; Sroda S; Raveton M; Reynaud S Environ Pollut; 2022 Oct; 311():120009. PubMed ID: 35998770 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]